OakChart

Ventas Inc

VTRReal Estate·REIT - Healthcare Facilities·USA·Large·NYSE·Nov 11 • 3:59 PM ET

90.42+0.08 (0.09%)
2026-11-11 22:38 CET
Market cap
47,773.60 USD m
Revenue, TTM
6,784.37 USD m
Net income, TTM
262.06 USD m
Free cash flow, TTM
1,500.28 USD m
EPS diluted, TTM
0.53
P/E
171.02
Compare

Price

VTR against its 20, 50 and 200-day averages
2050200missearnings
80.0090.00100.006.8M13.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26VTRclose 90.4220-day 86.6150-day 86.52200-day 87.0190.4252w high

11.0% under the 52-week high of 101.60 on 28 Jul 2026. 52-week low 73.82 on 8 Jan 2026. Last 15 sessions, 18.1% high to low

Volume 0.65× normal · the line is the 50-bar volume average

Profile

VTR
52-week range, 60% of the way up
73.82101.6

Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. It operates through the following segments: Senior Housing Operating Portfolio (SHOP), Outpatient Medical and Research Portfolio (OM&R), and Triple-net Leased Properties (NNN). The SHOP segment is involved in owning and investing in senior housing communities throughout the United States and Canada. The OM&R segment refers to acquiring, owning, development, leasing and managing outpatient medical buildings and research centers throughout the United States. The NNN segment focuses on investing and owning senior housing communities, skilled nursing facilities, long-term acute care facilities, freestanding inpatient rehabilitation facilities, and other healthcare facilities throughout the United States and the United Kingdom. The company was founded in 1983 and is headquartered in Chicago, IL.

IndexS&P 500, RUI
Employees542
IPOSep 19, 1989
Beta0.76
ATR, 14d2.16
Rel volume0.65
Short float2.84%
Insider own0.54%
Inst own101.39%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap48.85B
Enterprise Value61.89B
Income262.06M
Sales6.78B
Book/sh29.89
Cash/sh0.43
Dividend Est.2.08 (2.30%)
Dividend TTM2.04 (2.26%)
Dividend Ex-DateSep 30, 2026
Dividend Gr. 3/5Y2.17% -2.15%
Payout353.33%
Employees542
IPOSep 19, 1989

Ratios

P/E171.02
Forward P/E105.18
PEG3.63
P/S7.20
P/B3.02
P/C212.72
P/FCF32.56
EV/EBITDA25.14
EV/Sales9.12
Quick Ratio1.26
Current Ratio1.26
Debt/Eq0.81
LT Debt/Eq0.78
Option/ShortYes / Yes

Earnings

EPS (ttm)0.53
EPS next Y0.86
EPS next Q0.15
EPS this Y4.17%
EPS next Y52.82%
EPS next 5Y28.96%
EPS past 3/5Y- -14.17%
Sales past 3/5Y12.23% 8.99%
EPS Y/Y TTM0.00%
Sales Y/Y TTM22.13%
EPS Q/Q-11.58%
Sales Q/Q23.02%
EarningsOct 27 AMC
EPS/Sales Surpr.-19.80% 3.57%

Ownership

Insider Own0.54%
Insider Trans0.05%
Inst Own101.39%
Inst Trans2.02%
ROA0.91%
ROE1.86%
ROIC0.93%
Gross Margin18.02%
Oper. Margin14.60%
Profit Margin3.86%
SMA204.40%
SMA504.51%
SMA2003.92%
Trades-

Technical

Shs Outstand528.82M
Shs Float525.98M
Short Float2.84%
Short Ratio4.12
Short Interest14.96M
52W High101.60 -11.00%
52W Low73.82 22.49%
Volatility2.45% 2.49%
ATR (14)2.16
RSI (14)62.62
Beta0.76
Rel Volume0.65
Avg Volume3.63M
Volume2,376,644

Performance

Perf Week1.37%
Perf Month7.84%
Perf Quarter0.14%
Perf Half Y0.08%
Perf YTD16.85%
Perf Year18.71%
Perf 3Y115.38%
Perf 5Y68.04%
Perf 10Y56.94%
Recom1.52
Target Price99.67
Prev Close90.34
Price90.42
Change %0.09%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 15, 2026ResumedJJefferiesBuy$102+12.8%
Jul 07, 2026InitiatedBBarclaysEqual Weight$99+9.5%
Jun 17, 2026ResumedRRaymond JamesOutperform$94+4.0%
Jan 09, 2026InitiatedGGoldmanBuy$94+4.0%
Oct 01, 2025InitiatedCCantor FitzgeraldOverweight$77-14.8%
Sep 19, 2025InitiatedUUBSNeutral$73-19.3%
Jun 23, 2025UpgradeJJP MorganNeutral → Overweight$72-20.4%
Mar 07, 2025UpgradeAArgusHold → Buy
Jan 17, 2025UpgradeRRobert W. BairdNeutral → Outperform$66 → $65-28.1%
Oct 01, 2024UpgradeWWells FargoEqual Weight → Overweight$61 → $71-21.5%

Peers

Mkt cap
TickerCompanyMkt cap
WELLWelltower Inc181.46B
AHRAmerican Healthcare REIT Inc13.86B
DOCHealthpeak Properties Inc14.40B
JANJanus Living Inc10.10B
SBRASabra Healthcare REIT Inc5.49B
HRHealthcare Realty Trust Inc6.52B
OHIOmega Healthcare Investors Inc14.64B
CTRECareTrust REIT Inc9.95B
NHINational Health Investors Inc3.24B
LTCLTC Properties Inc2.47B

Insider trading

latest 14 of 30
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
EMBLER MICHAEL JDirectorJun 03 '26Buy78.812,500197,02519,202Jun 05 04:15 PM
RAKOWICH WALTER CDirectorMay 14 '26Sale90.201,152103,91528,349May 15 05:01 PM
Walter C. RakowichDirectorMay 14 '26Proposed Sale90.161,152103,864May 14 04:04 PM
GREGORY LIEBBEOfficerMar 02 '26Proposed Sale86.3117,2481,488,620Mar 02 04:08 PM
Roberts Carey S.EVP and GCFeb 11 '26Sale85.0035,5323,020,11772,755Feb 13 04:10 PM
CAREY SHEA ROBERTSOfficerFeb 11 '26Proposed Sale85.0035,5323,020,117Feb 11 04:13 PM
CAFARO DEBRA AChairman and CEOFeb 06 '26Option Exercise73.7110,322760,8351,124,356Feb 10 04:05 PM
CAFARO DEBRA AChairman and CEOFeb 06 '26Sale82.2310,322848,7511,114,034Feb 10 04:05 PM
CAFARO DEBRA AOfficerFeb 06 '26Proposed Sale82.2310,322848,751Feb 06 04:26 PM
CAFARO DEBRA AChairman and CEOFeb 02 '26Option Exercise73.7110,322760,8351,124,356Feb 03 04:31 PM
CAFARO DEBRA AChairman and CEOFeb 02 '26Sale77.6610,322801,6051,114,034Feb 03 04:31 PM
CAFARO DEBRA AOfficerFeb 02 '26Proposed Sale77.6610,322801,606Feb 02 04:41 PM
CAFARO DEBRA AChairman and CEOJan 02 '26Option Exercise73.7110,322760,8351,156,017Jan 06 05:50 PM
CAFARO DEBRA AChairman and CEOJan 02 '26Sale77.2610,322797,4751,145,695Jan 06 05:50 PM

Held by

AUM
TickerCompanyAUM
VNQVanguard Real Estate Index Fund ETFAUM: 38.99B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VOOVanguard S&P 500 ETFAUM: 1054.75B
VOVanguard Morningstar Mid-Cap ETFAUM: 107.07B
IVViShares Core S&P 500 ETFAUM: 871.38B
SPYSPDR S&P 500 ETF TrustAUM: 793.23B
SCHHSchwab U.S. REIT ETFAUM: 11.94B
XLREState Street Real Estate Select Sector SPDR ETFAUM: 8.46B
VOTVanguard Morningstar Mid-Cap Growth ETFAUM: 18.66B
VUGVanguard Morningstar Growth ETFAUM: 217.67B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-270.1300.1620.1301,8321,7697
2026Q22026-07-290.1400.1420.1421,7301,6816
2026Q12026-04-270.1100.1230.1151,6571,5856
2025Q42026-02-050.1500.1010.1461,5661,5046
2025Q32025-10-290.1400.0920.1431,4891,4377
2025Q22025-07-300.1500.1350.1491,4211,3794
2025Q12025-04-300.1000.0960.1051,3581,3165
2024Q42025-02-120.1300.0630.1331,2871,2576
2024Q32024-10-300.050-0.0240.0461,2361,2125
2024Q22024-08-010.0500.0400.0471,2011,1936
2024Q12024-05-01-0.040-0.326-0.0361,2001,1645
2023Q42024-02-14-0.230-0.164-0.2251,1641,1487
2023Q32023-11-02-0.180-0.019-0.1771,1501,1187
2023Q22023-08-030.2600.0220.2561,1061,0906
2023Q12023-05-080.040-0.1030.0431,0771,0406
2022Q42023-02-09-0.110-0.008-0.1131,0511,0426

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY1.1401.2791.1403,7463,678
2019FY1.1701.4191.1713,8733,799
2020FY1.1700.9541.1663,7953,760
2021FY0.1300.1700.1273,8283,740
2022FY-0.120-0.014-0.1274,1294,096
2023FY-0.100-0.040-0.1024,4984,464
2024FY0.1900.1020.1954,9244,871
2025FY0.5400.4850.5405,8345,746
2026FY-0.563--6,990
2027FY-0.860--7,769
2028FY-1.158--8,565
2029FY-1.780--9,308

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0711701,8261,7391,885
2026Q4S2026-11-0211801,8261,7391,885
2026Q4S2026-10-3011601,8181,7391,885
2026Q4S2026-10-2911401,8091,7391,885
2026Q4S2026-10-2811201,7971,7391,866
2026Q4S2026-10-2711201,7971,7391,866
2026Q4S2026-10-2411301,7971,7391,866
2026Q4S2026-10-1911401,7971,7391,866
2026Q4S2026-10-1710501,8031,7611,866
2026Q4S2026-10-1410601,8031,7611,866
2026Q4S2026-10-0710901,8031,7611,866
2026Q4S2026-09-239801,8081,7691,866
2026Q4S2026-08-3110801,8011,7391,866
2026Q4S2026-08-299801,7941,7391,832

Estimate history

EPS, annual3.7831.141.1711.1660.127-0.127-0.1020.1950.5430.5287
Period201720182019202020212022202320242025TTM
EPS, quarterly0.0460.1330.1050.1490.1430.1460.1150.1420.126
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual3574.1493745.813872.753795.3573828.0074129.1934497.8274946.5665836.386784.37
Period201720182019202020212022202320242025TTM
Sales, quarterly1236.3151287.0571358.0741420.8931488.9961566.0171656.9441729.6141831.791
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual356.186356.572372.809374.609399.42399.697402.101437.081474.926528.82
Period201720182019202020212022202320242025MRQ
Shares, quarterly419.267437.081451.211454.249469.449474.926486.097512.946528.82
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue6,784.375,836.384,946.574,497.834,129.193,828.013,795.363,872.753,745.81
Total Expenses5,794.074,943.174,240.323,832.713,595.823,224.293,050.822,870.932,800.19
Operating Income990.30893.21706.25665.12533.38603.72744.531,001.82945.62
Unusual Expense139.70106.44107.06235.71159.96326.02194.40190.74118.30
Net Income Before Taxes209.56247.3750.58-98.09-57.8661.39344.65382.99376.04
Income Taxes-61.98-14.15-37.77-9.54-16.934.83-96.53-56.31-39.95
Consolidated Net Income271.54261.5288.35-30.30-40.9356.56441.19439.30415.99
Net Income From Continuing Operations262.06251.3881.15-40.97-47.4549.01439.15433.02409.48
Net Income262.06251.3881.15-40.97-47.4549.01439.15433.02409.47
EPS (Recurring)0.690.700.370.310.170.721.531.531.37
EPS (Basic, Before Extraordinaries)0.540.550.20-0.10-0.130.131.181.181.15
EPS (Diluted)0.530.540.19-0.10-0.130.131.171.171.14
Non-Operating Income (Expense)-9.0143.0542.8246.6236.28223.77264.0623.57-8.79
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-30.5724.4130.4024.2523.2915.6924.7621.27
Price To Earnings Ratio170.87170.87-4,886.27-391.1242.1649.1451.41
Price To Sales Ratio6.506.134.964.454.075.164.865.515.62
Gross Margin18.0218.8718.5717.1418.3219.8923.7029.7031.08
Operating Margin14.6015.3014.2814.7912.9215.7719.6225.8725.24
Net Margin3.864.311.64-0.91-1.151.2811.5711.1810.93
Shares Outstanding528.82474.93437.08402.10399.70399.42374.61372.81356.57
Market Capitalization47,773.6047,773.6024,705.0020,054.6718,007.3020,405.8818,370.8321,521.7820,885.46

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,831.791,729.611,656.941,566.021,489.001,420.891,358.071,287.06
Total Expenses1,560.191,473.481,429.981,330.421,252.551,188.411,139.691,111.72
Operating Income271.60256.13226.96235.60236.45232.48218.38175.34
Unusual Expense57.5941.8635.414.8433.8939.5328.0822.64
Net Income Before Taxes47.9846.6043.1171.8762.3675.3437.8013.19
Income Taxes-19.30-25.62-15.94-1.12-6.343.87-10.56-45.54
Consolidated Net Income67.2872.2259.0572.9968.7171.4648.3658.73
Net Income From Continuing Operations65.3870.5755.9170.2066.0568.2646.8756.84
Net Income65.3870.5755.9170.2066.0568.2646.8756.84
EPS (Recurring)0.200.200.170.150.190.210.150.17
EPS (Basic, Before Extraordinaries)0.130.140.120.150.140.150.110.13
EPS (Diluted)0.130.140.110.150.140.150.100.13
Non-Operating Income (Expense)-4.65-7.647.70-4.4217.9332.68-3.1413.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.684.20-4.97----
Price To Earnings Ratio170.87160.84150.83146.25161.83190.84361.13-
Price To Sales Ratio6.506.866.496.385.845.476.045.11
Gross Margin17.9717.7818.0718.3119.4919.7920.1019.86
Operating Margin14.8314.8113.7015.0415.8816.3616.0813.62
Net Margin3.574.083.374.484.444.803.454.42
Shares Outstanding528.82512.95486.10474.93469.45454.25451.21437.08
Market Capitalization47,773.6043,171.9038,842.6436,347.9431,808.4328,504.3930,090.5424,705.00

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments786.14957.23563.46170.75196.60451.64146.10131.46188.25
Short Term Receivables350.70310.81194.11187.54176.88169.71278.83250.02267.76
Investments24,304.0622,826.6521,882.1521,769.8022,416.0021,500.3322,734.7820,850.1322,028.67
Investment in Unconsolidated Affiliates718.18721.75678.52675.31597.07507.46104.32105.20173.38
Net Property, Plant & Equipment0.000.000.000.000.000.000.000.000.00
Deferred Tax Assets2.801.931.7510.4911.159.9947.49--
Other Intangible Assets1,430.061,368.541,405.441,343.961,320.091,290.281,380.671,247.741,296.48
Total Assets27,591.9426,186.9124,725.4324,157.8424,717.7923,929.4024,692.2122,584.5623,954.54
Total Debt13,284.0813,815.7513,767.5912,579.3212,224.7812,105.3312,409.9710,733.7011,276.06
Long Term Debt11,088.5112,009.3212,503.4111,664.4711,502.9211,509.3111,525.5810,327.0711,276.06
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities23.418.1524.5035.5759.2662.64200.83205.22250.09
Other Liabilities1,323.501,223.181,086.301,056.621,207.711,247.761,262.281,185.901,337.71
Total Liabilities14,630.9815,047.0814,878.3913,671.5113,491.7413,415.7213,873.0812,124.8212,863.87
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity12,527.2510,771.279,488.0610,152.9710,854.3910,180.1710,445.8910,215.8610,866.23
Total Shareholders Equity12,527.2510,771.279,488.0610,152.9710,854.3910,180.1710,445.8910,215.8610,866.23
Accumulated Minority Interest433.71368.56358.98333.36371.66333.51373.24243.88224.45
Total Equity12,960.9611,139.839,847.0410,486.3311,226.0410,513.6810,819.1310,459.7411,090.67
Total Liabilities & Stockholders Equity27,591.9426,186.9124,725.4324,157.8424,717.7923,929.4024,692.2122,584.5623,954.54
Book Value Per Share26.3824.6423.6025.4027.1827.1828.0228.6530.51
Tangible Book Value Per Share24.1522.2320.9822.7724.5424.3625.1925.6927.58
Full-Time Employees542498486451434448516500493
Price to Book Ratio3.022.532.041.741.881.802.062.041.99
Return on Assets0.930.32-0.17-0.190.201.811.831.765.76
Return on Equity2.160.80-0.42-0.450.474.264.193.8812.72
Return on Invested Capital1.060.36-0.19-0.220.222.021.971.996.13
Quick Ratio0.510.670.590.390.480.890.520.763.38
Current Ratio0.510.670.590.390.480.890.520.763.38

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Funds from Operations1,902.151,631.001,294.181,248.141,189.261,087.731,328.351,478.241,494.64
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital55.1849.4343.81-53.60-40.78-43.77121.83-40.29-55.72
Cash from Operating Activities1,957.331,680.431,337.991,194.541,148.471,043.961,450.181,437.951,438.92
Capital Expenditures-457.06-363.86-281.61-259.42-222.13-185.28-148.23-156.72-131.86
Net Assets From Acquisitions0.00-2.06-11.06-0.11-0.17-24.22-8.240.00-4.72
Sale of Fixed Assets and Businesses1.240.083.7031.865.371.731.316.281.88
Purchase or Sale of Investments-4,342.90-2,369.26-2,107.39-29.11-679.10-558.00302.32-1,458.93392.01
Purchase of Investments-4,515.62-2,631.24-2,443.35-523.33-792.92-1,746.53-861.05-2,624.09-873.32
Sale Or Maturity of Investments172.72261.98335.96494.22113.821,188.531,163.371,165.161,265.33
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources9.275.013.5417.5813.701.280.2130.186.89
Cash from Investing Activities-4,789.45-2,730.09-2,392.82-239.20-882.33-764.48147.37-1,579.19264.20
Cash Dividends Paid-976.27-860.06-740.33-723.56-720.32-686.89-928.81-1,157.72-1,127.14
Change in Capital Stock4,246.492,452.251,988.50109.067.20625.5169.89976.06-1.37
Repurchase of Common Pref Stock0.000.000.000.00-1.49-0.10-0.57-2.20-1.37
Sale of Common Pref Stock4,246.492,452.251,988.50109.068.69625.6170.47978.260.00
Proceedsfrom Stock Options4,168.002,341.391,962.45107.320.00617.4455.36942.090.00
Issuance or Reduction of Debt, Net0.00-670.52249.1397.75468.80-447.95-409.01363.50-615.25
Change in Long Term Debt0.00-6.77-7.10-12.41468.80-447.95-409.01363.50-615.25
Issuance of Long Term Debt0.000.000.000.001,071.371,787.06724.923,557.312,850.32
Reduction of Long Term Debt0.00-6.77-7.10-12.41-602.57-2,235.02-1,133.93-3,193.81-3,465.58
Net Financing Active Other Cash Flow-73.28-60.43-80.61-88.97-44.81-26.64-25.16-27.45-15.33
Other Financing Activities Uses-40.42-37.21-64.65-80.06-38.62-20.34-20.23-18.93-19.03
Cash from Financing Activities2,820.54875.731,452.58-563.88-289.13-535.97-1,293.10154.39-1,759.10
Exchange Rate Effect-1.352.84-3.981.26-2.871.451.091.48-0.81
Net Change in Cash-12.92-171.10393.77392.72-25.85-255.04305.5414.64-56.79
Free Cash Flow1,500.281,316.561,056.38935.13926.34858.691,301.941,281.231,307.06
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow84.2078.4277.5894.6681.64114.9549.48172.92117.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments229.63223.82201.29786.14242.55676.76
Short Term Receivables382.89365.18360.24350.70335.23291.73
Investments27,787.5626,972.6025,029.4924,304.0624,139.6623,382.26
Investment in Unconsolidated Affiliates690.29692.41712.19718.18751.23726.40
Net Property, Plant & Equipment0.000.000.000.000.000.00
Deferred Tax Assets2.813.132.672.802.322.17
Other Intangible Assets1,532.211,398.751,380.671,430.061,454.721,395.62
Total Assets30,625.3829,655.9027,686.5427,591.9426,925.7026,474.93
Total Debt12,725.4412,979.2712,788.5013,284.0812,855.5813,343.83
Long Term Debt12,261.8812,248.1911,188.9111,088.5112,748.2412,792.84
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities31.8030.7426.7323.4120.9213.99
Other Liabilities1,515.721,434.261,294.741,323.501,275.501,195.95
Total Liabilities14,272.9614,444.2614,109.9714,630.9814,152.0014,553.77
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity15,807.0614,649.4013,124.9612,527.2512,361.9211,529.39
Total Shareholders Equity15,807.0614,649.4013,124.9612,527.2512,361.9211,529.39
Accumulated Minority Interest545.36562.23451.62433.71411.79391.77
Total Equity16,352.4215,211.6313,576.5812,960.9612,773.7111,921.16
Total Liabilities & Stockholders Equity30,625.3829,655.9027,686.5427,591.9426,925.7026,474.93
Book Value Per Share29.8928.5627.0026.3826.3325.38
Tangible Book Value Per Share27.8926.5024.8324.1524.0823.05
Full-Time Employees---542--
Price to Book Ratio3.023.293.102.942.762.48
Return on Assets0.910.940.970.930.910.75
Return on Equity1.862.012.122.162.151.81
Return on Invested Capital0.230.260.230.300.260.28
Quick Ratio1.260.710.340.512.891.49
Current Ratio1.260.710.340.512.891.49

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations501.37489.89440.77470.13393.44395.04
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-11.7677.88-46.1635.23-14.8680.30
Cash from Operating Activities489.60567.76394.61505.36378.58475.34
Capital Expenditures-144.55-101.83-72.97-137.71-92.17-75.07
Net Assets From Acquisitions0.000.000.000.00-2.060.00
Sale of Fixed Assets and Businesses0.011.210.010.000.000.00
Purchase or Sale of Investments-1,157.47-1,862.56-996.10-326.78-1,087.64-129.93
Purchase of Investments-1,176.69-1,868.40-1,049.97-420.56-1,098.98-270.67
Sale Or Maturity of Investments19.225.8453.8893.7811.34140.74
Other Uses0.000.000.000.000.000.00
Other Sources4.272.380.562.072.290.58
Cash from Investing Activities-1,297.74-1,960.80-1,068.49-462.42-1,179.59-204.42
Cash Dividends Paid-267.04-253.35-230.19-225.68-218.39-216.96
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1,342.831,749.46809.73344.471,018.60193.30
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1,342.831,749.46809.73344.471,018.60193.30
Proceedsfrom Stock Options1,343.351,748.94796.46279.25999.07186.94
Issuance or Reduction of Debt, Net-251.06-65.94-463.50390.61-424.42188.07
Change in Long Term Debt0.000.000.000.00-1.351.13
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.00-1.351.13
Net Financing Active Other Cash Flow-11.66-13.76-33.40-14.46-8.32-16.18
Other Financing Activities Uses-10.05-6.19-12.57-11.59-7.50-13.70
Cash from Financing Activities814.331,416.4189.95499.86368.13156.97
Exchange Rate Effect-0.38-0.85-0.910.79-1.332.91
Net Change in Cash5.8222.53-584.85543.59-434.21430.79
Free Cash Flow345.06465.93321.64367.65286.41400.27
Price to Free Cash Flow84.2085.9882.1181.4977.7064.81

Revenue breakdown

Canada2024: 526.58M 2025: 552.92M
United Kingdom2024: 30.74M 2025: 71.23M
United States2024: 4.37B 2025: 5.21B
Consolidation, Policy2024: 51.83M 2025: 58.34M
Outpatient Medical And Research Portfolio2024: 877.59M 2025: 897.90M
Senior Living Operations2024: 3.37B 2025: 4.28B
Triple Net Leased Properties2024: 622.05M 2025: 601.58M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.84%15.0M526.0M3.60M
2026-10-152.83%14.4M510.2M3.58M
2026-09-303.23%16.5M510.2M3.47M
2026-09-153.88%19.8M510.2M3.54M
2026-08-313.99%20.4M510.0M3.61M
2026-08-144.65%23.7M510.0M3.80M
2026-07-314.64%23.7M510.0M4.12M
2026-07-155.12%24.7M483.4M4.43M
2026-06-304.72%22.8M483.4M4.31M
2026-06-154.76%23.0M482.7M4.07M
2026-05-294.78%23.1M483.4M3.94M
2026-05-154.57%22.1M483.4M3.81M
2026-04-304.11%19.9M483.5M3.56M
2026-04-154.03%19.0M472.9M3.10M
2026-03-313.87%18.3M471.8M3.05M
2026-03-134.21%19.8M471.8M2.98M
2026-02-273.96%18.7M471.8M3.04M
2026-02-133.12%14.7M471.8M3.06M
2026-01-303.06%14.4M472.6M3.02M
2026-01-153.12%14.6M467.4M2.99M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call45.0043.4047.500.003.7990.000.000.974-0.1200.008
call47.5040.9044.900.003.5050.000.000.972-0.1190.009
call50.0038.4042.4028.803.2770.000.000.970-0.1170.009
call55.0033.4037.400.002.8510.000.000.966-0.1140.011
call60.0028.4032.4024.502.46040.000.000.960-0.1110.012
call65.0023.4026.400.001.6970.000.000.952-0.1070.014
call70.0018.4021.1011.661.2665.000.000.943-0.1010.016
call72.5016.2018.6017.001.1301.000.000.927-0.1150.019
call75.0013.4017.004.801.30411.000.000.918-0.1110.021
call77.5010.9013.705.850.90112.000.000.907-0.1060.023
call80.008.9011.709.140.91442.000.000.892-0.1000.026
call82.507.309.308.200.78943.0030.000.753-0.2440.044
call85.004.207.004.900.6782890.000.709-0.2240.048
call87.502.304.603.120.53061.000.000.640-0.2070.053
call90.000.303.501.770.58944.000.000.538-0.1940.056
call92.500.102.800.600.66210.007.000.422-0.1900.055
call95.000.000.550.300.3646740.000.243-0.1090.044
call97.500.001.150.530.4741520.000.180-0.1070.037
call1000.001.750.450.5741520.000.139-0.1020.031
call1050.002.152.530.7551920.000.112-0.1150.027
call1100.002.150.250.9171830.000.096-0.1250.024
call1150.001.151.001.0657.000.000.085-0.1330.022
call1200.002.150.001.2020.000.000.078-0.1390.020
call1250.001.150.341.3293.000.000.072-0.1450.019
call1300.002.150.001.4490.000.000.067-0.1500.018
put45.000.002.150.002.5570.000.00-0.025-0.1200.008
put47.500.002.150.002.3820.000.00-0.027-0.1190.009
put50.000.002.150.002.2150.000.00-0.029-0.1170.009
put55.000.002.150.001.9040.000.00-0.034-0.1140.011
put60.000.002.150.241.6186.000.00-0.040-0.1100.012
put65.000.000.550.141.35118.000.00-0.047-0.1050.014
put70.000.000.400.831.0996151.00-0.057-0.0990.016
put72.500.002.151.791.0313.000.00-0.073-0.1130.019
put75.000.001.750.050.90618.000.00-0.081-0.1080.021
put77.500.001.300.050.78326.000.00-0.093-0.1030.023
put80.000.000.500.930.66179.001.00-0.107-0.0970.026
put82.500.002.200.490.97737.000.00-0.247-0.2410.044
put85.000.002.405.800.8482000.00-0.291-0.2200.048
put87.500.202.950.700.77035.000.00-0.360-0.2030.053
put90.000.003.307.600.6265.000.00-0.462-0.1900.056
put92.501.804.104.100.5180.000.00-0.577-0.1860.055
put95.004.006.509.100.6560.000.00-0.757-0.1050.044
put97.505.909.004.400.7940.000.00-0.819-0.1020.037
put1008.3011.400.000.8970.000.00-0.860-0.0960.031
put10513.5016.500.001.1420.000.00-0.887-0.1090.027
put11018.0021.400.001.3140.000.00-0.903-0.1180.024
put11523.0026.600.001.5470.000.00-0.914-0.1260.022
put12028.0031.600.001.7130.000.00-0.922-0.1320.020
put12533.0036.600.001.8680.000.00-0.928-0.1370.019
put13038.0041.600.002.0130.000.00-0.932-0.1410.018

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-05SEC
2026-11-06424B2SEC
2026-11-05FWPFiling under Securities Act Rule 163/433 of free writing prospectuses.SEC
2026-11-05424B5SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-154Statement of changes in beneficial ownership of securities2026-10-15SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-073Initial statement of beneficial ownership of securities2026-10-05SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-158-KCurrent report2026-09-10SEC
2026-08-1413F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-06-30SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-08-043Initial statement of beneficial ownership of securities2026-08-01SEC
2026-07-3010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-27SCHEDULE 13G/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-06197.03K100
2026-0500103.92K1
2026-040000
2026-030000
2026-02004.67M3
2026-01003.11M2
2025-1200831.42K1
2025-110010.47M12

Institutional holders

Manager% owned
BlackRock, Inc.11.47%
JPMORGAN CHASE & CO8.99%
VANGUARD PORTFOLIO MANAGEMENT LLC8.77%
FMR LLC6.74%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP6.28%
GEODE CAPITAL MANAGEMENT, LLC2.90%
PRINCIPAL FINANCIAL GROUP INC2.69%
Capital World Investors2.40%
APG Asset Management US Inc.2.33%

Funds

Fund% owned
VANGUARD REAL ESTATE INDEX FUND3.72%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD 500 INDEX FUND2.59%
VANGUARD MID-CAP INDEX FUND2.17%
iShares Core S&P 500 ETF1.38%
Fidelity 500 Index Fund1.23%
Income Fund of America1.21%
SPDR S&P 500 ETF TRUST1.21%
JPMorgan Equity Income Fund1.12%
VANGUARD VALUE INDEX FUND0.95%

OakChart. VTR. Cached 15 minutes.